PDCD1 and neoplasm: The activation of the PD-1/PD-L1 pathway triggers the phosphorylation of ERK and mTOR in MDA-MB-231 cells, potentiates the proliferative potential of tumor cells, and initiates the resistance to chemotherapy [68].